Overexpression of S14 in Neu-induced mammary tumors shortened tumor latency and increased tumor cell proliferation (Figure 3); and these differences in tumor growth were associated with elevated tumor levels of MCFA relative to Neu controls (Figure 4). Here, ERBB2 is linked to breast cancer.